PharmaCyte Biotech (PMCB) Income towards Parent Company (2010 - 2026)
PharmaCyte Biotech's Income towards Parent Company came in at -$5.08 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$8.36 million a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Income towards Parent Company (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, PharmaCyte Biotech reported Income towards Parent Company of -$16.15 million; for FY2026 (ended Apr 30, 2026), it was -$19.42 million.
- Going back by fiscal year, Income towards Parent Company was $30.66 million in FY2025, $333,763 in FY2024, -$4.32 million in FY2023 and -$4.24 million in FY2022.
- The five-year range for quarterly Income towards Parent Company is -$8.36 million (fiscal Q1 2026) to $23.42 million (fiscal Q1 2025).
- Business Quant data shows PMCB's Income towards Parent Company at -$4.39 million (Q4 2026), $746,860 (Q3 2026) and -$7.42 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | 4.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -5.08 Mn |
| Apr 30, 2026 | -4.39 Mn |
| Jan 31, 2026 | 746,860.00 |
| Oct 31, 2025 | -7.42 Mn |
| Jul 31, 2025 | -8.36 Mn |
| Apr 30, 2025 | 11.75 Mn |
| Jan 31, 2025 | -3.05 Mn |
| Oct 31, 2024 | -1.47 Mn |
| Jul 31, 2024 | 23.42 Mn |
| Apr 30, 2024 | 1.35 Mn |
| Jan 31, 2024 | -619,537.00 |
| Oct 31, 2023 | 2.79 Mn |
| Jul 31, 2023 | -3.18 Mn |
| Apr 30, 2023 | -126,338.00 |
| Jan 31, 2023 | -764,136.00 |
| Oct 31, 2022 | -1.88 Mn |
| Jul 31, 2022 | -1.55 Mn |
| Apr 30, 2022 | -1.42 Mn |
| Jan 31, 2022 | -811,290.00 |
| Oct 31, 2021 | -979,746.00 |
API Access
PharmaCyte Biotech Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();